logo

For the Inventor, By the Inventor

CH

Antares Pharma Ipl Ag


USPTO Granted Patents = 16



Forward Citations = 427

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Arnaud Grenier (9 out of 14 patents)

silverMedal Dario Norberto R Carrara (6 out of 6 patents)

bronzeMedal Leah M Lehman (6 out of 6 patents)

4.  Stephen M Simes (6 out of 6 patents)

5.  Celine Besse (5 out of 5 patents)

6.  Dario Carrara (2 out of 4 patents)

7.  Gabriel Porto (2 out of 2 patents)

8.  Jorge Rodriguez (2 out of 2 patents)

9.  R Dario Norberto Carrara (2 out of 2 patents)

10.  Regine Sitruk-Ware (1 out of 6 patents)

11.  Dario Norberto Ramon Carrara (1 out of 1 patent)

12.  Etienne Pionnier (1 out of 1 patent)

13.  Isabelle Rault (1 out of 2 patents)

14.  Dario Norberto Carrara (0 patent)

15.  Jorge c/o Antares Pharma Ag Rodriguez (0 patent)


16 patents:

1. 9682087 - Nestorone®/estradiol transdermal gel (2017-06-20),
2. 8980309 - Transdermal testosterone formulation for minimizing skin residues (2015-03-17),
3. 8980290 - Transdermal compositions for anticholinergic agents (2015-03-17),
4. 8652491 - Transdermal compositions for anticholinergic agents (2014-02-18),
5. 8647665 - Methods of treating hot flashes with formulations for transdermal or transmucosal application (2014-02-11),
6. 8338400 - Methods and apparatus for transdermal or transmucosal application of testosterone (2012-12-25),
7. 8268346 - Methods of treating hot flashes with formulations for transdermal or transmucosal application (2012-09-18),
8. 8067399 - Method and apparatus for transdermal or transmucosal application of testosterone (2011-11-29),
9. 7470433 - Formulations for transdermal or transmucosal application (2008-12-30),
10. 7425340 - Permeation enhancing compositions for anticholinergic agents (2008-09-16),
11. 7404965 - Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels (2008-07-29),
12. 7387788 - Pharmaceutical compositions of nicotine and methods of use thereof (2008-06-17),
13. 7335379 - Transdermal pharmaceutical formulation for minimizing skin residues (2008-02-26),
14. 7214381 - Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels (2007-05-08),
15. 7198801 - Formulations for transdermal or transmucosal application (2007-04-03),
Antares Pharma IPL AG is a leading global provider of self-injection systems and technologies. With over 20 years of experience, the company specializes in developing innovative drug delivery solutions for patients and healthcare professionals. Antares Pharma's products include autoinjectors, pen injectors, and wearable injectors, designed to improve patient convenience, safety, and compliance. The company is committed to delivering high-quality, reliable, and user-friendly injection systems that enhance the overall treatment experience.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#53 in

#732 in Switzerland

#36,676 in the World

...
CH

Antares Pharma Ipl Ag

Forward Citations = 427

13 inventors:

goldMedal Arnaud Grenier (9 out of 14 patents)

silverMedal Dario Norberto R Carrara (6 out of 6 patents)

bronzeMedal Leah M Lehman (6 out of 6 patents)

4.  Stephen M Simes (6 out of 6 patents)

5.  Celine Besse (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…